LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
TNF mediated inflammation is critical in autoimmune mediated pathology, however many patients are refractory to current anti-TNF therapeutics. Here the authors show induction of several death ligands, in addition to TNF is sufficient to cause fatal dermatitis in a LUBAC deficient murine model of dis...
Guardado en:
Autores principales: | Lucia Taraborrelli, Nieves Peltzer, Antonella Montinaro, Sebastian Kupka, Eva Rieser, Torsten Hartwig, Aida Sarr, Maurice Darding, Peter Draber, Tobias L. Haas, Ayse Akarca, Teresa Marafioti, Manolis Pasparakis, John Bertin, Peter J. Gough, Philippe Bouillet, Andreas Strasser, Martin Leverkus, John Silke, Henning Walczak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78dd2d56aa01420b8690887b14510d40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores
por: Min Wu, et al.
Publicado: (2019) -
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis.
por: Carlos López-Gómez, et al.
Publicado: (2011) - Trail & Landscape
-
On the corruption trail
por: Lynne Amepou
Publicado: (1996) -
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
por: Harsimran D. Singh, et al.
Publicado: (2017)